The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis - Wikidata - awgldk - TriplyDB

The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis

The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis

http://www.wikidata.org/entity/Q26764752

about

Risk factors for therapeutic failure to meglumine antimoniate and miltefosine in adults and children with cutaneous leishmaniasis in Colombia: A cohort study.Safety and efficacy of current alternatives in the topical treatment of cutaneous leishmaniasis: a systematic review.Intralesional meglumine antimoniate for the treatment of localised cutaneous leishmaniasis: a retrospective review of a Brazilian referral centre Chemotherapy of leishmaniasis: present challenges.Clinical and laboratory profiles of patients with early spontaneous healing in cutaneous localized leishmaniasis: a historical cohort study.Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.Efficacy of azole therapy for tegumentary leishmaniasis: A systematic review and meta-analysis.An overview of skin lesions adapted to Cutaneous Leishmaniasis in Persian Medicine.Depot Subcutaneous Injection with Chalcone CH8-Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres as a Single-Dose Treatment of Cutaneous Leishmaniasis.Meglumine antimoniate intralesional infiltration for localised cutaneous leishmaniasis: a single arm, open label, phase II clinical trial.

P2860

Q33570722-76752314-7CEE-4E54-88E4-9370357312EC Q36331429-DC3D415B-7B18-4DA3-A609-8C593AB19091 Q37167729-E0D79848-4AB9-4648-B580-DD308AED01EE Q39011875-00CD5D58-842D-4ADF-A5B8-EBEC52374B05 Q41336329-D9EFE34A-A56B-439F-89CE-E808B652D8FA Q41677439-3FE095F5-1F5F-41C7-87F0-973F70061F7A Q42708364-0DB73E56-8E68-4868-88D7-512CEDADB5AA Q49876091-B4A50988-15A2-4AD5-96C2-0514C600BCCB Q51771418-F7D70651-60B9-49BA-83F0-F55FECC6F907 Q55398190-D457E5DE-CEC0-49E3-B4C9-7C3D7FD6FC91

P2860

The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis

http://www.wikidata.org/entity/Q26764752

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@ast

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@en

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@nl

type

label

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@ast

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@en

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@nl

prefLabel

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@ast

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@en

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@nl

P1433

Q26764752-4DFAFE41-1843-4C3C-B276-E60163AA264E

P1476

Q26764752-09BBA46D-32A4-4CEA-918B-2F04B21E6164

P2093

Q26764752-1374CB35-6644-4669-BDC8-5C0A6F4084B9

Q26764752-39826AFD-D463-4244-B4AF-767A68121705

Q26764752-981CD9AC-E1B7-42F1-ADF3-C07995362902

Q26764752-B400740D-4CDF-4B9D-82FA-DC698B13FA18

Q26764752-B462E91F-F1FE-4C43-BEDE-C46AF2233906

Q26764752-E3B02755-5F49-4B5E-8694-D38D26003993

P275

Q26764752-339AB3C7-878B-4737-849F-8784688EAACD

P2860

Q26764752-00924A84-3AA4-4A6D-85AB-B758BC5CD700

Q26764752-0ACF42C2-2EE9-47A5-B84A-0350B1DB7BC3

Q26764752-2C0F81CA-1A98-4869-B6B0-C4283F06AFA7

Q26764752-514D0764-C0F9-4DD4-9C39-435FC26B8AF6

Q26764752-55B323D8-32ED-4C33-950F-331A20366500

Q26764752-5A1D2051-F30F-49F7-B51F-34B47223A0B4

Q26764752-5E9A52A8-6B97-4EBC-B92D-D14F3EE27F28

Q26764752-63927312-DE1E-489F-B624-83C5378493A8

Q26764752-70A7C4EF-1F84-4937-A004-EDB472117E69

Q26764752-745EF7B5-E7BA-432C-A0A1-BDAC32D915EC

P304

Q26764752-D9719036-3E25-46BA-B7DC-BD82CA04627E

P31

Q26764752-6597B549-57CA-4D18-8BB8-4461E25F6AA5

Q26764752-8C113CF8-F8B4-4320-83B7-E626470504CB

Q26764752-9972CE9E-B5EA-4D18-9C8F-4C290066B6B6

Q26764752-E8E56D11-E0FA-4A71-9201-4056E1868A7E

P3181

Q26764752-126518A8-45DD-4C9B-AB60-864E5E25F360

P356

Q26764752-1F37261F-0525-4B4A-AB91-4A3D08DCE636

P407

Q26764752-AA4E8E3C-2084-488F-BD0B-B053FF4A2D76

P433

Q26764752-C771D534-6418-4168-B761-D51D930F17EC

P478

Q26764752-911A42B8-C68B-4FCA-BCA9-D81B7064AD01

P5008

Q26764752-E5A87729-61C9-4638-BDC5-9203C51825B5

P577

Q26764752-68D3077E-D0C2-4B2A-B647-7EBBC8481B96

P5875

Q26764752-280F2420-432A-4DDA-8EE0-460E4900D0F0

P698

Q26764752-C01F709B-AAF5-42F4-9B71-EEA0A893D826

P921

Q26764752-4A68BB10-C43A-4131-A760-30E81A74D646

Q26764752-5BF145C3-7F31-4BAB-A154-83FD1216E7A7

Q26764752-D0759AED-0BAE-4DB0-89C6-7CB23FF44004

P932

Q26764752-8DC69E40-F362-4943-A996-36DA80B56525

P3181

P356

JOURNAL.PONE.0149697

P1433

P1476

The Cure Rate after Placebo or ...... matic Review and Meta-Analysis

@en

P2093

Ana Rabello

http://www.w3.org/2001/XMLSchema#string

Gláucia Fernandes Cota

http://www.w3.org/2001/XMLSchema#string

Marcos Roberto de Sousa

http://www.w3.org/2001/XMLSchema#string

Priscila Said Saleme

http://www.w3.org/2001/XMLSchema#string

Tatiani Oliveira Fereguetti

http://www.w3.org/2001/XMLSchema#string

Thais Kawagoe Alvarisa

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

Interventions for American cutaneous and mucocutaneous leishmaniasis

Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues

The ethics of placebo-controlled trials--a middle ground

The continuing unethical use of placebo controls

Treatment of New World cutaneous leishmaniasis with miltefosine

World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects

Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis

Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala

Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala

P304

e0149697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P3181

4376351

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0149697

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-02-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

295244521

http://www.w3.org/2001/XMLSchema#string

P698

26894430

http://www.w3.org/2001/XMLSchema#string

P921

cutaneous leishmaniasis

pharmaceutical preparation

P932

4760744

http://www.w3.org/2001/XMLSchema#string